Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.
about
Protective vaccination against papillomavirus-induced skin tumors under immunocompetent and immunosuppressive conditions: a preclinical study using a natural outbred animal modelTRIM21: a cytosolic Fc receptor with broad antibody isotype specificityFc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeuticsTissue-resident memory T cellsThe Role of FcRn in Antigen PresentationResearch gaps in defining the biological link between HIV risk and hormonal contraceptionUnraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsTargeting FcRn for the modulation of antibody dynamicsThe neonatal Fc receptor, FcRn, as a target for drug delivery and therapyThe Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cellsIntranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccineIgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infectionsTransient antibody-mucin interactions produce a dynamic molecular shield against viral invasionHumoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.Interactions between HIV-1 and mucosal cells in the female reproductive tractDivergent outcomes following transcytosis of IgG targeting intracellular and extracellular chlamydial antigensLive simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.Innate and adaptive immune responses in male and female reproductive tracts in homeostasis and following HIV infection.An intravaginal ring for the sustained delivery of antibodies.A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.Cervico-vaginal immunoglobulin G levels increase post-ovulation independently of neutrophils.Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.Bovine FcRn-mediated human immunoglobulin G transfer across the milk-blood barrier in transgenic mice.Regulation of immune responses by the neonatal fc receptor and its therapeutic implicationsA truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccinesHerpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection.Intracellular neutralization of viral infection in polarized epithelial cells by neonatal Fc receptor (FcRn)-mediated IgG transport.Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.Targeting the vaginal mucosa with human papillomavirus pseudovirion vaccines delivering simian immunodeficiency virus DNA.FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin.Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominis.A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C.Localization of neonatal Fc receptor for IgG in aggregated lymphoid nodules area in abomasum of Bactrian camels (Camelus bactrianus) of different agesUnique features of antiviral immune system of the vaginal mucosaThe immunologic functions of the neonatal Fc receptor for IgGComparative Evaluation of HIV-1 Neutralization in External Secretions and Sera of HIV-1-Infected Women.Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances.Broadly neutralizing antibody specificities detected in the genital tract of HIV-1 infected women
P2860
Q21131365-0B42677B-C328-492B-BD2C-611BB5295D02Q26779753-E45E6C75-98A6-41DB-A67A-C2E1F5E9EC2CQ26822421-710CF4C9-2D48-429D-A69E-E3F938B6C9E0Q26829804-8C19A47F-A597-4A8E-9403-23FAA6929AD4Q26852988-AC0E1455-D9DD-4704-92D1-F1B2FFFA1C3EQ27002559-F923FB08-FBDB-4CA3-9CBC-0917231F60F7Q27027238-BD0211A4-A3FA-4147-9603-FB9813F8DC44Q28080589-B3634EB5-D3F0-4DA8-A7A7-A89F770EB768Q28257521-81A35EED-1276-4BCF-8841-3D8E9D786A36Q28302792-0A2B3773-6569-4A21-96AE-14E47CC279BEQ28728786-2B5CD7D4-0655-4FF8-A5FA-45D519B29AD1Q30585914-91AB088E-D2E3-48EC-A286-F2555F3F5B21Q33595754-7102BAF2-9852-4972-BC8B-9EA1E185D29DQ33624872-B61965CD-7EB6-4539-8F6E-7DF84AD0DB06Q33815410-D1EF2E17-DDCC-4D4F-8133-6703976C1C48Q33870404-7C4165FE-3E81-4A20-AF2A-71A6234475D3Q34146728-3816448A-5814-416F-A93C-29504A526130Q34339797-40B87F02-EB4B-4B86-A0C0-059F7CEF7241Q34389166-4F20EB53-A81A-4846-8525-7C4EFD332E3CQ34414463-9184AA0E-B3FF-4082-A8F3-FFC7448E1DEEQ34640774-EDB7D0E0-2B97-4B0C-9E8E-0B9EA2FFCB85Q34653920-74FB577E-CA2C-4AA4-844A-38C318152022Q34783912-8033624C-594D-4673-AECD-4DA47148C24EQ34818194-9E6374B4-51C8-4500-BF5B-191B1D9EC7E0Q35063993-914AFD69-5C48-4E52-BDF1-0EF9993312ABQ35156674-AB6ABBEB-7F87-4C26-B122-A4E7A8BCA994Q35274924-4AB8447D-6F8C-480D-BF21-C224C2441A95Q35546930-42AD3EB6-15F6-499D-B43C-EC0EE756FD8EQ35612850-E377429D-6309-4DD0-87BF-E7735AE13082Q35618379-115F835B-EF3A-4F3D-9DBF-850D577C6048Q35658952-E86A0A74-4583-4F3F-9E0A-13FEC44F7EEDQ35670904-60620536-3127-411D-92DB-5E6819B0586FQ35952105-902DAB32-1E0A-4312-A280-AAAC0CFB5B23Q36135698-47405DF1-547F-4D2D-8413-BB331F00F9F2Q36169844-0161291E-97D4-438B-8B3C-D82C36287627Q36177229-F295A121-8F7C-47CB-B92F-A4EFB8A9785BQ36542347-2DDC5B92-CEA5-4BA2-A4B8-32099F184BEAQ36547166-87171BA6-8676-484D-B2C8-8998A87A6227Q36589179-B2E9BA6D-1BDA-4D3B-A0CC-D8335C2407B1Q36753653-0D246943-1AA9-4962-B500-4D70159C0FB0
P2860
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor (FcRn) confers protective immunity to vaginal infection.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Transfer of IgG in the female ...... immunity to vaginal infection.
@ast
Transfer of IgG in the female ...... immunity to vaginal infection.
@en
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor
@nl
type
label
Transfer of IgG in the female ...... immunity to vaginal infection.
@ast
Transfer of IgG in the female ...... immunity to vaginal infection.
@en
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor
@nl
prefLabel
Transfer of IgG in the female ...... immunity to vaginal infection.
@ast
Transfer of IgG in the female ...... immunity to vaginal infection.
@en
Transfer of IgG in the female genital tract by MHC class I-related neonatal Fc receptor
@nl
P2093
P2860
P356
P1476
Transfer of IgG in the female ...... immunity to vaginal infection.
@en
P2093
Derry C Roopenian
Rongyu Zeng
Senthilkumar Palaniyandi
Wenbin Tuo
Xiaoping Zhu
P2860
P304
P356
10.1073/PNAS.1012861108
P407
P577
2011-02-28T00:00:00Z